Laquinimod beneficial in relapsing-remitting MS?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1645, 2008-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferons in Relapsing-Remitting Multiple Sclerosis: Are There Benefits from Long-Term Use?

By Oscar Fernández

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1057-1070

Adis International

Access to resources Recommend Favorite

Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis

By Thööne Jan Gold Ralf

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 365-370

Informa Healthcare

Access to resources Recommend Favorite

Novel vaccine show promise for relapsing-remitting MS

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

IFN- treatment cost driver in relapsing-remitting MS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

IFN- treatment cost driver in relapsing-remitting MS

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite